sutures newsletter


Douglas to Lead New Orbital, Thyroid Eye Disease Center

Raymond S. Douglas, MD, PhD

Renowned oculoplastic surgeon Raymond S. Douglas MD, PhD, has joined Cedars-Sinai to lead its new International Orbital and Thyroid Eye Disease Center.

Douglas will develop a multidisciplinary clinic to provide highly specialized care to patients with thyroid eye disease (TED or Graves' eye disease) and other complex orbital diseases such as cancer and trauma.

One in 100 people will be affected by TED, an autoimmune condition in which immune cells attack the thyroid gland, which responds by secreting an excess amount of thyroid hormone.

At the clinic, patients will have coordinated care by recognized specialists, including orbital surgeons, strabismus surgeons, orthoptists, neuro-ophthalmologists, dry eye specialists, endocrinologists and rheumatologists.

The program will continue to expand research into the treatments on thyroid-associated orbitopathy. Many of the processes by which TED causes inflammation of tissue surrounding the eye have been unraveled and new treatments are on the horizon.

Patients with this condition may experience severe swelling and bulging eyes, which in advanced cases can lead to loss of vision. The center plans to evaluate several promising therapeutic agents that interrupt the disease process identified through research by Douglas.

Douglas comes to Cedars-Sinai from the University of Michigan Health System, where he served as professor of Ophthalmology and Visual Sciences and director of the Thyroid Eye Disease Center.

His new position, he said, will set the course for Cedars-Sinai to become the pre-eminent international center for the treatment of TED and other orbital conditions.

"This multidisciplinary approach will help us deliver even higher-quality care and a more comprehensive treatment plan for our patients," Douglas said. "The physicians at Cedars-Sinai are world leaders and together we will provide concierge cutting edge care to patients in Los Angeles and the world."